Few stocks arrive at an earnings report with less goodwill banked than Lufax Holding. Shares have fallen 42% since the company last reported, a period in which the S&P 500 was essentially flat, and the stock now trades at $0.87, less than half its 200-day moving average of $1.80. The question for the third-quarter release, due after the close on October 27, is no longer whether the business can impress. It is whether it can show enough stability to stop the bleeding in the share price.

The starting point is a loss. Last quarter Lufax reported a net loss of $0.04 per share on revenue of $917.8 million, which leaves the China-based personal financial services and credit platform still working to prove it can return to consistent profitability. The Street's revenue consensus for the coming quarter sits at 3.88 billion, a figure that appears to be on a different currency basis than last quarter's dollar-denominated result, so a simple sequential comparison would be misleading. A usable earnings-per-share consensus is not available, and the company has not issued formal guidance to anchor expectations. That absence matters. Without a management target, the market will judge the quarter largely on direction: is the loss shrinking, and is the top line holding steady?

For a lender of this kind, the quality of the earnings will matter as much as the headline figures. A narrower loss driven by lower credit costs and steadier loan performance would carry far more weight than one produced by trimming expenses alone, because cost cuts can only go so far when revenue is under pressure. Readers should look closely at whether new lending volumes are stabilizing, whether funding and guarantee-related costs are easing, and whether provisions for bad loans are trending down. Improvement on those fronts would suggest the business is finding a floor. Further deterioration would indicate the loss last quarter was not a trough but a waypoint.

The stock's behavior suggests the market has been bracing for the latter. Since the last report, shares have traded between $1.54 and $0.84, and the current price sits only a few cents above the bottom of that range. That leaves the stock testing support rather than threatening any breakout, and a disappointing print could push it to fresh lows. On the other hand, a valuation this compressed means the bar for a relief rally is relatively low; simply avoiding new bad news could be enough to prompt some short covering or bargain hunting.

Sentiment hints at exactly that kind of tentative thaw. Earnings Whispers readings remain negative at 11.1% bearish, but that is a notable improvement from 25.7% bearish heading into the prior report. Investors are still skeptical, just less uniformly so than they were three months ago. That shift does not predict the outcome, but it does suggest some participants believe much of the damage is already priced in.

Ultimately, this report comes down to trajectory. If Lufax can show a smaller loss, steadier revenue and signs that credit quality is no longer slipping, the case that the business is bottoming gains real support, and a stock pinned near its lows would have room to respond. If losses widen or credit metrics worsen, the steep decline since last quarter will look less like an overreaction and more like an accurate read on a business that has not yet found its footing.